GLAND PHARMA
Back to Balance Sheet
|
GLAND PHARMA Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹163 Cr | ₹170 Cr | ₹84 Cr | ₹88 Cr | ₹74 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of GLAND PHARMA ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹163 Cr |
| Mar2024 | ₹170 Cr |
| Mar2023 | ₹84 Cr |
| Mar2022 | ₹88 Cr |
| Mar2021 | ₹74 Cr |
How is Deferred Tax Assets / Liabilities of GLAND PHARMA Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹163 Cr | -4.09 | |
| Mar2024 | ₹170 Cr | 101.52 | |
| Mar2023 | ₹84 Cr | -4.05 | |
| Mar2022 | ₹88 Cr | 18.79 | |
| Mar2021 | ₹74 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of GLAND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAND PHARMA | ₹41,129.6 Cr | 1.9% | 10.9% | 35.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹465,195.0 Cr | 0.9% | 5.6% | 14.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹180,823.0 Cr | 1.2% | 3.7% | -1.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹165,725.0 Cr | 4.4% | 10.3% | 42.1% | Stock Analytics | |
| CIPLA | ₹116,467.0 Cr | -1.7% | 3.1% | -4.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,987.0 Cr | 0.2% | 5.7% | 6% | Stock Analytics | |
GLAND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAND PHARMA | 1.9% |
10.9% |
35.9% |
| SENSEX | -0.5% |
3% |
-8.5% |
You may also like the below Video Courses